Concepedia

Author

Serafina Mammoliti

Ospedale Policlinico San MartinoORCID

Also Known As

S Mammoliti, S. Mammoliti, Serafina Mammoliti

95

Publications

1.9K

Citations

22

H-Index

45

Concepts

All Affiliations

Ospedale Policlinico San MartinoAlleanza Contro il CancroIstituti di Ricovero e Cura a Carattere ScientificoUniversity of GenoaIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
SM

About

Serafina Mammoliti is an author at Ospedale Policlinico San Martino specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

18

1.3K

2

Public Health

2

2

105

3

Natural Sciences

1

1

31

4

Allergy

1

1

69

5

Biochemistry

1

1

31

Serafina Mammoliti

×

27

Publications

1.4K

Citations

20

H-Index

YearCitations

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

Chiara Cremolini, Carlotta Antoniotti, Daniele Rossini,

The Lancet Oncology

2020

309

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial

Sandro Pignata, Domenica Lorusso, Florence Joly,

The Lancet Oncology

2021

144

A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites

Nicoletta Colombo, Giorgia Mangili, Serafina Mammoliti,

Gynecologic Oncology

2011

94

High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.

Pierfranco Conté, Milena Bruzzone, F Carnino,

Journal of Clinical Oncology

1996

90

Neoadjuvant chemotherapy and vaginal radical trachelectomy for fertility-sparing treatment in women affected by cervical cancer (FIGO stage IB–IIA1)

Pierangelo Marchiolè, J Tigaud, S. Costantini,

Gynecologic Oncology

2011

81

Monoclonal antibodies which react with the T cell receptor γ/δ recognize different subsets of CD3WT31<sup>‐</sup> T lymphocytes

Silvano Ferrini, Ignazia Prigione, Cristina Bottino,

European Journal of Immunology

1989

69

Concomitant versus sequential administration of epirubicin and paclitaxel as first‐line therapy in metastatic breast carcinoma

Pierfranco Conté, Valentina Guarneri, Paolo Bruzzi,

Cancer

2004

69

Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19)

Cláudia Marchetti, Gabriella Ferrandina, Gennaro Cormio,

Gynecologic Oncology

2016

64

Cerebral Metastases Secondary to Ovarian Cancer: Still an Unusual Event

Milena Bruzzone, Elisabetta Campora, Silvana Chiara,

Gynecologic Oncology

1993

55

Intravenous aflibercept in patients with platinum‐resistant, advanced ovarian cancer: Results of a randomized, double‐blind, phase 2, parallel‐arm study

William P. Tew, Nicoletta Colombo, Isabelle Ray‐Coquard,

Cancer

2013

51

Page 1